Moreover, the inhibition of USP7 has shown potential in triple-negative breast cancer by destabilizing FOXM1, thus suppressing tumor growth and underscoring its significance as a therapeutic target in cancer treatment [19]. The gene discussed is FOXM1; the disease is triple-negative breast carcinoma.